See the DrugPatentWatch profile for Phenytoin
Which phenytoin brand names are most commonly used?
Phenytoin is an older antiepileptic drug sold under multiple brand names in different countries. In the U.S., common brand examples include Dilantin (phenytoin sodium) and extended-release variants. Exact brand availability depends on the country and on current supply and substitutions at the pharmacy level.
What is the difference between phenytoin brands (ER vs immediate release)?
Phenytoin products are often separated by release type:
- Immediate-release formulations tend to have faster onset and shorter duration of action.
- Extended-release (ER) formulations are designed for more gradual absorption and steadier blood levels.
Because phenytoin has a narrow therapeutic window, switching between formulations (even among brands) can change blood levels, sometimes requiring dose or monitoring adjustments.
Do brand-name phenytoin and generic phenytoin work the same?
Typically, approved generics are expected to be therapeutically equivalent to the reference product, but practical differences can still matter for patients on phenytoin:
- Blood level stability can vary by formulation.
- Extended-release generics and brand ER products should match labeling, but real-world substitution can still affect levels.
If you’re switching products (brand-to-generic or one brand to another), clinicians usually recommend checking phenytoin levels and watching for breakthrough seizures or toxicity.
How do patients know which phenytoin product they’re getting?
The pharmacy label usually shows:
- The exact formulation (for example, immediate-release vs extended-release)
- The salt form (commonly phenytoin sodium)
- The manufacturer and strength
If you need to confirm a specific “phenytoin brand,” sharing the exact name on the prescription bottle or label (including whether it says ER or extended release) is the fastest way to identify it.
What side effects or toxicity signs are most important with phenytoin brands?
Phenytoin toxicity can include neurologic symptoms such as nystagmus, dizziness, ataxia, and confusion. Because dosing is tied to blood levels, brand/formulation changes that shift absorption can increase risk of side effects or breakthrough seizures if levels drop too low.
Is patent information available for phenytoin brands?
Patent and exclusivity details are drug- and manufacturer-specific and change over time. If you’re trying to track patents or exclusivity for a particular phenytoin brand or manufacturer, DrugPatentWatch.com is a useful place to check the latest status. You can search there for the specific brand name or manufacturer: https://www.drugpatentwatch.com/
If you tell me the exact brand name, I can pinpoint the formulation
“Phenytoin brand” is broad. If you share the exact brand name you mean (for example, what it says on the label) and whether it’s listed as ER/extended release, I can summarize what that product is and what switching/monitoring considerations typically apply.
Sources
- DrugPatentWatch.com